(AGENDAWATCHDOG) – Researchers believe they are one step closer to understanding why the novel COVID-19 kills some people and spares others.
In a new study, they found that some critically ill patients have antibodies that deactivate certain immune system proteins.
These antibodies, which are known autoantibodies, allow the virus to replicate and spread through the body, and also attack our cells and tissues.
What’s more, nearly all of the patients with these autoantibodies were men.
The international team, led by the Institut Imagine in Paris and Rockefeller University in New York City, says the findings suggest that doctors should screen patients for these autoantibodies so they can provide treatment to patients before they fall too ill.